WARNING:
Major Prostate Biopsy Billing Changes Ahead
CPT® code 55700 will be deleted on January 1, 2026 and replaced with 11 new CPT® codes that optimize reimbursement for advanced technologies such as MRI-US Fusion targeted biopsies that improve patient care.
Click here for the 2026 AMA CPT biopsy codes
Coming soon. CMS 2026 Physician Fee Schedule
If your practice is still performing ultrasound-guided sextant biopsies or traveling off-site to complete biopsies, your revenue will be impacted.
Don’t wait until January to act.
Book a consultation today to prepare your team, stay ahead of the revenue impact, and learn how a risk-free trial now can optimize your 2026 bottom line and workflow efficiency.
Put Your Reimbursement Plan Into Action Before Jan 1
UC-CARE is helping practices optimize their 2026 reimbursement NOW.
In-office
MRI-US fusion maximizes practice RVUs, reimbursement, patient access, and overall efficiency.
Anytime
ASC/Hospital-based MRI-US fusion reduces costs while improving patient scheduling and revenue performance.
Our no-cost, risk-free offer is available for a limited time:
No long-term commitments
No minimum volume required
No-cost returns
Premium Prostate MRI-Fusion Navigation at an Affordable Cost for Practices
With the lowest upfront costs, flexible payment plans, pay-per-procedure options, and the ability to improve revenue, efficiency, patient access and diagnostic accuracy, the Navigo 4D Prostate Fusion Biopsy System has long been a powerful growth strategy for urology practices.
​
With the upcoming reimbursement changes, maximizing revenue has become even more critical.​
Accuracy
Real-time patient movement compensation and the SmartBx biopsy preservation system.
Automation
Integrates with most ultrasounds, adapts to your settings, and automates biopsy marking for best-in-class ease of use.
Affordability
Aligns costs to your reimbursement to maximize cash flow and profitability from Day 1.
Premium Features
Implement our risk-free offer NOW to:
Future-proof your 2026 billing
Lock in 2025 pay-per-procedure pricing
Lead the market—and be ready to maximize both patient care and your 2026 bottom line
What Practices Are Saying
The Navigo 4D Fusion Navigation System aligns with the new CPT® codes that go live on January 1, 2026, which means simpler reimbursement and less financial risk, without the cost barriers that come with other fusion biopsy systems.
But don’t just take our word for it.
See what group, solo and hospital practices already using Navigo 4D are saying.
A UC-Care specialist will reach out within one business day to discuss your goals and guide you through the next steps toward compliance and profitability.